NASDAQ:CRON - Cronos Group Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cronos Group Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $8.34 +0.17 (+2.08 %) (As of 01/23/2020 07:54 AM ET) Add Compare Today's Range$8.17Now: $8.34▼$8.6850-Day Range$6.58MA: $7.23▼$8.5552-Week Range$6.04Now: $8.34▼$25.10Volume12.69 million shsAverage Volume11.33 million shsMarket Capitalization$2.91 billionP/E Ratio9.59Dividend YieldN/ABeta3.2 ProfileAnalyst RatingsAdvanced ChartEarningsInstitutional OwnershipHeadlinesOptions ChainSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Cronos Group Inc, formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations MMPR. The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Medicinals & botanicals Sub-IndustryN/A SectorFinance Current SymbolNASDAQ:CRON Previous Symbol CUSIPN/A CIKN/A Webhttp://www.thecronosgroup.com/ Phone212-590-9070Debt Debt-to-Equity RatioN/A Current Ratio3.45 Quick Ratio3.36Price-To-Earnings Trailing P/E Ratio9.59 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$12.12 million Price / Sales240.03 Cash FlowN/A Price / Cash FlowN/A Book Value$0.91 per share Price / Book9.16Profitability EPS (Most Recent Fiscal Year)($0.08) Net Income$-14,640,000.00 Net Margins4,086.41% Return on Equity31.88% Return on Assets17.34%Miscellaneous Employees291 Outstanding Shares348,820,000Market Cap$2.91 billion Next Earnings Date3/24/2020 (Estimated) OptionableOptionable Receive CRON News and Ratings via Email Sign-up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:CRON Rates by TradingView Cronos Group (NASDAQ:CRON) Frequently Asked Questions What is Cronos Group's stock symbol? Cronos Group trades on the NASDAQ under the ticker symbol "CRON." How were Cronos Group's earnings last quarter? Cronos Group Inc (NASDAQ:CRON) announced its quarterly earnings results on Tuesday, November, 12th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.03) by $0.01. The firm had revenue of $10.10 million for the quarter, compared to the consensus estimate of $10.42 million. Cronos Group had a net margin of 4,086.41% and a return on equity of 31.88%. View Cronos Group's Earnings History. When is Cronos Group's next earnings date? Cronos Group is scheduled to release their next quarterly earnings announcement on Tuesday, March 24th 2020. View Earnings Estimates for Cronos Group. What price target have analysts set for CRON? 14 brokers have issued 12-month price objectives for Cronos Group's stock. Their forecasts range from $12.00 to $26.00. On average, they anticipate Cronos Group's stock price to reach $17.49 in the next twelve months. This suggests a possible upside of 109.7% from the stock's current price. View Analyst Price Targets for Cronos Group. What is the consensus analysts' recommendation for Cronos Group? 14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 1 sell rating, 8 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Cronos Group. Has Cronos Group been receiving favorable news coverage? News stories about CRON stock have trended somewhat negative this week, according to InfoTrie Sentiment. The research firm identifies positive and negative press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Cronos Group earned a news sentiment score of -1.3 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Cronos Group. Are investors shorting Cronos Group? Cronos Group saw a increase in short interest in the month of December. As of December 13th, there was short interest totalling 61,160,000 shares, an increase of 6.3% from the November 28th total of 57,550,000 shares. Based on an average trading volume of 7,110,000 shares, the days-to-cover ratio is currently 8.6 days. Currently, 34.8% of the company's shares are sold short. View Cronos Group's Current Options Chain. Who are some of Cronos Group's key competitors? Some companies that are related to Cronos Group include Canopy Growth (CGC), STADA Arzneimittel (STDAF), Aurora Cannabis (ACB), Tilray (TLRY), USANA Health Sciences (USNA), Canopy Rivers (RIV), Foamix Pharmaceuticals (FOMX), Sundial Growers (SNDL), Chromadex (CDXC), Happiness Biotech Group (HAPP), Mediwound (MDWD), Natural Alternatives International (NAII), Mannatech (MTEX), Cyanotech (CYAN) and GLG Life Tech (GLGLF). What other stocks do shareholders of Cronos Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Tilray (TLRY), Aphria (APHA), Dollar Tree (DLTR), NVIDIA (NVDA), Advanced Micro Devices (AMD), Micron Technology (MU), Alibaba Group (BABA) and KushCo (KSHB). Who are Cronos Group's key executives? Cronos Group's management team includes the folowing people: Mr. Michael Gorenstein, Chairman, Pres & CEO (Age 31)Mr. David Hsu, Chief Operating OfficerMs. Xiuming Shum, Gen. Counsel & Corp. Sec.Mr. Jeffrey Jacobson, Head of Sales & Bus. Devel.Mr. William Hilson, Chief Commercial Officer Who are Cronos Group's major shareholders? Cronos Group's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Wedbush Securities Inc. (0.08%), Janney Montgomery Scott LLC (0.03%), Gainplan LLC (0.01%), AE Wealth Management LLC (0.01%), Exane Derivatives (0.00%) and IFP Advisors Inc (0.00%). Which institutional investors are selling Cronos Group stock? CRON stock was sold by a variety of institutional investors in the last quarter, including Exane Derivatives and IFP Advisors Inc. Which institutional investors are buying Cronos Group stock? CRON stock was bought by a variety of institutional investors in the last quarter, including Wedbush Securities Inc., Janney Montgomery Scott LLC, Gainplan LLC and AE Wealth Management LLC. How do I buy shares of Cronos Group? Shares of CRON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Cronos Group's stock price today? One share of CRON stock can currently be purchased for approximately $8.34. How big of a company is Cronos Group? Cronos Group has a market capitalization of $2.91 billion and generates $12.12 million in revenue each year. The company earns $-14,640,000.00 in net income (profit) each year or ($0.08) on an earnings per share basis. Cronos Group employs 291 workers across the globe.View Additional Information About Cronos Group. What is Cronos Group's official website? The official website for Cronos Group is http://www.thecronosgroup.com/. How can I contact Cronos Group? Cronos Group's mailing address is 720 KING STREET W SUITE 320, TORONTO A6, M5V 2T3. The company can be reached via phone at 212-590-9070. MarketBeat Community Rating for Cronos Group (NASDAQ CRON)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 391 (Vote Outperform)Underperform Votes: 466 (Vote Underperform)Total Votes: 857MarketBeat's community ratings are surveys of what our community members think about Cronos Group and other stocks. Vote "Outperform" if you believe CRON will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CRON will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/23/2020 by MarketBeat.com StaffFeatured Article: What is the S&P/TSX Index?
